These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1751360)

  • 1. Chronic cutaneous graft-versus-host disease: successful treatment with UVB.
    van Dooren-Greebe RJ; Schattenberg A; Koopman RJ
    Br J Dermatol; 1991 Nov; 125(5):498-9. PubMed ID: 1751360
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of narrow band UVB in the treatment of cutaneous GvHD: an Indian experience.
    George L; Peter D; Chopra M; George B; Abraham A; Mathews V; Srivastava A; Pulimood SA
    Bone Marrow Transplant; 2016 Jul; 51(7):988-90. PubMed ID: 26901707
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcomes Using Narrowband UVB Phototherapy for Acute Cutaneous Graft Versus Host Disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Snyder AN; Wine Lee L; Jaroscak JJ; Donahoo LB; Hudspeth M
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e151-e153. PubMed ID: 33315852
    [No Abstract]   [Full Text] [Related]  

  • 4. Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients.
    Brazzelli V; Grasso V; Muzio F; Moggio E; Zecca M; Locatelli F; Borroni G
    Br J Dermatol; 2010 Feb; 162(2):404-9. PubMed ID: 19903177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease.
    Grundmann-Kollmann M; Martin H; Ludwig R; Klein S; Boehncke WH; Hoelzer D; Kaufmann R; Podda M
    Transplantation; 2002 Dec; 74(11):1631-4. PubMed ID: 12490799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case of thymoma-associated cutaneous graft-versus-host disease-like disease successfully improved by narrowband ultraviolet B phototherapy.
    Yatsuzuka K; Tohyama M; Oda F; Hashimoto T; Sayama K
    J Dermatol; 2018 Apr; 45(4):479-482. PubMed ID: 29215146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UVA1 therapy for sclerodermic graft-versus-host disease of the skin.
    Ständer H; Schiller M; Schwarz T
    J Am Acad Dermatol; 2002 May; 46(5):799-800. PubMed ID: 12004332
    [No Abstract]   [Full Text] [Related]  

  • 8. Thymoma-associated cutaneous graft-versus-host-like disease possibly treated with Narrow-band UVB phototherapy.
    Nakayama M; Itoh M; Kikuchi S; Tanito K; Nakagawa H
    Eur J Dermatol; 2016 Apr; 26(2):208-9. PubMed ID: 27018042
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life.
    Ziemer M; Thiele JJ; Gruhn B; Elsner P
    J Am Acad Dermatol; 2004 Aug; 51(2):318-9. PubMed ID: 15280858
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic graft-versus-host disease treated with UVB phototherapy.
    Enk CD; Elad S; Vexler A; Kapelushnik J; Gorodetsky R; Kirschbaum M
    Bone Marrow Transplant; 1998 Dec; 22(12):1179-83. PubMed ID: 9894721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet B irradiation: a new therapeutic concept for the management of oral manifestations of graft-versus-host disease.
    Elad S; Garfunkel AA; Enk CD; Galili D; Or R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Oct; 88(4):444-50. PubMed ID: 10519752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cutaneous and/or soft tissue manifestations of corticosteroids refractory chronic graft versus host disease (cGVHD) by a total nodal irradiation (TNI).
    Peyraga G; Lizee T; Gustin P; Clement-Colmou K; Di Bartolo C; Supiot S; Mahe MA; François S; Mege M
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28181304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narrowband UV-B Phototherapy for Steroid-Refractory Sclerotic Chronic Cutaneous Graft-vs-Host Disease.
    Sorenson E; McAndrew R; Patel V; Logan AC; Koo J; Levin E
    JAMA Dermatol; 2015 Jun; 151(6):635-7. PubMed ID: 25806783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of phototherapy in cutaneous chronic graft-vs-host disease: a retrospective study and review of the literature.
    Ballester-Sánchez R; Navarro-Mira MÁ; de Unamuno-Bustos B; Pujol-Marco C; Sanz-Caballer J; Botella-Estrada R
    Actas Dermosifiliogr; 2015 Oct; 106(8):651-7. PubMed ID: 26032871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of cutaneous Langerhans' cell histiocytosis with targeted narrowband ultraviolet B phototherapy in an infant.
    Do JE; Lee JY; Kim YC
    Clin Exp Dermatol; 2009 Oct; 34(7):e280-1. PubMed ID: 19438560
    [No Abstract]   [Full Text] [Related]  

  • 16. An appraisal of narrowband (TL-01) UVB phototherapy. British Photodermatology Group Workshop Report (April 1996).
    Br J Dermatol; 1997 Sep; 137(3):327-30. PubMed ID: 9349324
    [No Abstract]   [Full Text] [Related]  

  • 17. Phototherapy for sclerosing skin conditions.
    Teske NM; Jacobe HT
    Clin Dermatol; 2016; 34(5):614-22. PubMed ID: 27638441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Langerhans cell histiocytosis in an elderly man successfully treated with narrowband ultraviolet B.
    Imafuku S; Shibata S; Tashiro A; Furue M
    Br J Dermatol; 2007 Dec; 157(6):1277-9. PubMed ID: 17916205
    [No Abstract]   [Full Text] [Related]  

  • 19. [Phototherapy: UVB or UVA?].
    Jeanmougin M
    Ann Dermatol Venereol; 1991; 118(8):517-8. PubMed ID: 1952687
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous hardening in a patient with systemic sclerosis successfully treated with UVA-1 phototherapy.
    Cuenca-Barrales C; Navarro-Triviño FJ; Vega-Castillo JJ; Rodríguez-Pérez J; Ruiz-Villaverde R; Espelt-Otero JL
    Dermatol Ther; 2019 Nov; 32(6):e13133. PubMed ID: 31631448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.